Scott Ogg
10Patents
5h-index
20Co-inventors
66Inventor score
Filing activity: May 15, 1997 → Jan 10, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8461303B2 | LOX and LOXL2 inhibitors and uses thereof | Physics | 16 | Active |
| US8658167B2 | Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasis | Physics | 12 | Active |
| US9176139B2 | LOX and LOXL2 inhibitors and uses thereof | Physics | 9 | Active |
| US6225120A | Therapeutic and diagnostic tools for impaired glucose tolerance conditions | Physics | 7 | Expired |
| US8679485B2 | Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasis | Physics | 5 | Active |
| US6861256B2 | Therapeutic and diagnostic tools for impaired glucose tolerance conditions | Physics | 1 | Expired |
| US11814679B2 | Interleukin-10 production of antigen-specific CD8+ T cells and methods of use of same | Chemistry; Metallurgy | 0 | Active |
| US7041437B2 | Therapeutic and diagnostic tools for impaired glucose tolerance conditions | Physics | 0 | Expired |
| US10494443B2 | LOX and LOXL2 inhibitors and uses thereof | Physics | 0 | Active |
| US7414169B2 | Therapeutic and diagnostic tools for impaired glucose tolerance conditions | Physics | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.